Paper19906992
Role of HIV membrane in neutralization by two broadly neutralizing antibodies.
Alam SM and 10 others. Proc Natl Acad Sci U S A, 2009. Cited by 223 papers, by iCite.
Cite this record
ConductScience Library. Role of HIV membrane in neutralization by two broadly neutralizing antibodies. Papers, record 19906992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19906992
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Antibodies, Neutralizing | Major topic |
| HIV Infections | Major topic |
| HIV-1 | Major topic |
| Models, Molecular | Major topic |
| Viral Vaccines | Major topic |
| HIV Envelope Protein gp41 | |
| Humans | |
| Membranes, Artificial | |
| Mutation | |
| Neutralization Tests | |
| Protein Binding |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R21 AI069972 | NIAID NIH HHS | United States | R21AI069972 | PubMed and NIH | NIH RePORTER |
| Howard Hughes Medical Institute | United States | PubMed | PubMed |
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7973652 | Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. | Science | 1994 | https://conductscience.org/library/papers/7973652 | PubMed |
| 2 | 7692082 | A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. | J Virol | 1993 | https://conductscience.org/library/papers/7692082 | PubMed |
| 3 | 12644702 | Rapid evolution of the neutralizing antibody response to HIV type 1 infection. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12644702 | PubMed |
| 4 | 12860131 | Structural analysis of the epitope of the anti-HIV antibody 2F5 sheds light into its mechanism of neutralization and HIV fusion. | J Mol Biol | 2003 | https://conductscience.org/library/papers/12860131 | PubMed |
| 5 | 12379111 | A monomeric 3(10)-helix is formed in water by a 13-residue peptide representing the neutralizing determinant of HIV-1 on gp41. | Biochemistry | 2002 | https://conductscience.org/library/papers/12379111 | PubMed |
| 6 | 14990736 | The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5. | J Virol | 2004 | https://conductscience.org/library/papers/14990736 | PubMed |
| 7 | 16481622 | The HIV lipidome: a raft with an unusual composition. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/16481622 | PubMed |
| 8 | 16940516 | Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. | J Virol | 2006 | https://conductscience.org/library/papers/16940516 | PubMed |
| 9 | 9630213 | HIV entry and its inhibition. | Cell | 1998 | https://conductscience.org/library/papers/9630213 | PubMed |
| 10 | 9126269 | Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations. | Virology | 1997 | https://conductscience.org/library/papers/9126269 | PubMed |
| 11 | 17260969 | Exposure of the membrane-proximal external region of HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion. | Biochemistry | 2007 | https://conductscience.org/library/papers/17260969 | PubMed |
| 12 | 17039602 | A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses. | Virology | 2006 | https://conductscience.org/library/papers/17039602 | PubMed |
| 13 | 9442107 | Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41. | J Cell Biol | 1998 | https://conductscience.org/library/papers/9442107 | PubMed |
| 14 | 8551569 | Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. | J Virol | 1996 | https://conductscience.org/library/papers/8551569 | PubMed |
| 15 | 15860590 | Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. | Science | 2005 | https://conductscience.org/library/papers/15860590 | PubMed |
| 16 | 15307924 | Evaluation of the safety, immunogenicity, and protective efficacy of whole inactivated simian immunodeficiency virus (SIV) vaccines with conformationally and functionally intact envelope glycoproteins. | AIDS Res Hum Retroviruses | 2004 | https://conductscience.org/library/papers/15307924 | PubMed |
| 17 | 12478295 | HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. | Nature | 2002 | https://conductscience.org/library/papers/12478295 | PubMed |
| 18 | 11788027 | A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1. | AIDS Res Hum Retroviruses | 2001 | https://conductscience.org/library/papers/11788027 | PubMed |
| 19 | 9126268 | Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type-1 preparations. | Virology | 1997 | https://conductscience.org/library/papers/9126268 | PubMed |
| 20 | 9108481 | Core structure of gp41 from the HIV envelope glycoprotein. | Cell | 1997 | https://conductscience.org/library/papers/9108481 | PubMed |
Cited by187
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 223 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42931443 | Advances in HIV-1 Envelope-Based Vaccine Development. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42931443 | PubMed |
| 42536668 | htrSPRanalysis: An open source R package for expedited analysis of high-throughput binding kinetics data. | PLoS Comput Biol | 2026 | https://conductscience.org/library/papers/42536668 | PubMed |
| 42446980 | Structural basis of membrane engagement and polyreactivity control in HIV-1 MPER broadly neutralizing antibodies. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/42446980 | PubMed |
| 42360802 | Conformational variability of HIV-1 Env trimer and viral vulnerability. | Elife | 2026 | https://conductscience.org/library/papers/42360802 | PubMed |
| 41583464 | Viral glycoprotein-mediated entry and antibody-mediated immunity in HIV-1 and SARS-CoV-2 infection. | Front Immunol | 2025 | https://conductscience.org/library/papers/41583464 | PubMed |
| 41545420 | Heterologous immunization modulates B-cell epitope competition between helper peptides and the MPER segment in MPER/liposome vaccines. | NPJ Vaccines | 2026 | https://conductscience.org/library/papers/41545420 | PubMed |
| 41421345 | Probing the role of membrane in neutralizing activity of antibodies against influenza virus. | Structure | 2026 | https://conductscience.org/library/papers/41421345 | PubMed |
| 41280106 | Conformational Variability of HIV-1 Env Trimer and Viral Vulnerability. | bioRxiv | 2025 | https://conductscience.org/library/papers/41280106 | PubMed |
| 40511646 | Germline-Targeting Strategies to Induce bNAbs against HIV-1. | Curr HIV Res | 2026 | https://conductscience.org/library/papers/40511646 | PubMed |
| 40192122 | Ab initio prediction of specific phospholipid complexes and membrane association of HIV-1 MPER antibodies by multi-scale simulations. | Elife | 2025 | https://conductscience.org/library/papers/40192122 | PubMed |
| 39216479 | Decoupling HIV-1 antiretroviral drug inhibition from plasma antibody activity to evaluate broadly neutralizing antibody therapeutics and vaccines. | Cell Rep Med | 2024 | https://conductscience.org/library/papers/39216479 | PubMed |
| 38761800 | Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans. | Cell | 2024 | https://conductscience.org/library/papers/38761800 | PubMed |
| 38201237 | Determination of Binding Affinity of Antibodies to HIV-1 Recombinant Envelope Glycoproteins, Pseudoviruses, Infectious Molecular Clones, and Cell-Expressed Trimeric gp160 Using Microscale Thermophoresis. | Cells | 2023 | https://conductscience.org/library/papers/38201237 | PubMed |
| 37940661 | Inadequate structural constraint on Fab approach rather than paratope elicitation limits HIV-1 MPER vaccine utility. | Nat Commun | 2023 | https://conductscience.org/library/papers/37940661 | PubMed |
| 37632074 | Current ARTs, Virologic Failure, and Implications for AIDS Management: A Systematic Review. | Viruses | 2023 | https://conductscience.org/library/papers/37632074 | PubMed |
| 37549723 | Parameter estimation and identifiability analysis for a bivalent analyte model of monoclonal antibody-antigen binding. | Anal Biochem | 2023 | https://conductscience.org/library/papers/37549723 | PubMed |
| 36541800 | Enhancing HIV-1 Neutralization by Increasing the Local Concentration of Membrane-Proximal External Region-Directed Broadly Neutralizing Antibodies. | J Virol | 2023 | https://conductscience.org/library/papers/36541800 | PubMed |
| 36479128 | Autoreactivity and broad neutralization of antibodies against HIV-1 are governed by distinct mutations: Implications for vaccine design strategies. | Front Immunol | 2022 | https://conductscience.org/library/papers/36479128 | PubMed |
| 36142694 | Functional Delineation of a Protein-Membrane Interaction Hotspot Site on the HIV-1 Neutralizing Antibody 10E8. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36142694 | PubMed |
| 34505005 | Focal accumulation of aromaticity at the CDRH3 loop mitigates 4E10 polyreactivity without altering its HIV neutralization profile. | iScience | 2021 | https://conductscience.org/library/papers/34505005 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19906992
GET https://conductscience.org/api/papers/v1/19906992/references?page=2